For pharma
Poor adherence and lost follow-up is costly
-
Up to 50% of trial patients do not adhere to medications, costing pharma companies $637bn globally
-
Patients are less willing to share their data with pharma than mHealth
-
3 in 5 patients use tech to monitor their health, which has more than tripled in the last 5 years but only 13% have experienced virtual care
-
UK healthcare consumers’ top desired uses of virtual care are:
-
Medication and health behaviour reminders
-
Daily support for ongoing health issues
-
Follow-up after in-person appointments or after hospitalisation
-
Discussion of specific health concerns with providers
-
After-hours appointments and examination of non-urgent conditions
Our solution
Enhanced patient experience and care
-
A customised application with multiple means of communication - messaging, questionnaires, video calling
-
Medications adherence, symptoms and vitals monitoring in real-time
-
Real-time patient reported outcomes feedback via our PROMs dashboard
